Phosphodiesterase Type 5 Regulation in the Penile Corpora Cavernosa

被引:24
作者
Lin, Ching-Shwun [1 ]
机构
[1] Univ Calif San Francisco, Knuppe Mol Urol Lab, Dept Urol, San Francisco, CA 94115 USA
关键词
Penis; cAMP; cGMP; Promoter; Priapism; Hypoxia; Nitric Oxide Synthase; PDE5; DEPENDENT PROTEIN-KINASE; ALLOSTERIC CGMP-BINDING; ERECTILE FUNCTION; INTRONIC PROMOTER; PDE5; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; TESTOSTERONE; INHIBITION; SILDENAFIL;
D O I
10.1111/j.1743-6109.2008.01179.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Penile detumescence depends on the hydrolysis of cyclic guanosine monophosphate (cGMP) by phosphodiesterase type 5 (PDE5). It is hoped that a review of publications relevant to the regulation of PDES in the penis will be helpful to both scientists and clinicians who are interested in the sciences of erectile function/dysfunction. Aims. The aim of this article is to comprehensively review the mechanisms by which PDF5 activity and expression in the penis are regulated. All published studies relevant to PDE5 regulation in the penis or penile cells will be reviewed. Methods. Entrez (PubMed) was used to search for publications relevant to the topics of this review. Keywords used in the searches included vascular, cavernous, penis, smooth muscle, signaling molecules, erection, priapism, and PDE5. Articles that are dedicated to the study of erectile function/dysfunction were prioritized for citation. Results. Regulation of PDE5 can occur at both protein and gene levels. At protein level, PDE5 is activated by phosphorylation and/or allosteric cGMP binding. Deactivation is carried out by protein phosphatase I and thus linked to the Rho-kinase signaling pathway. Cleavage of PDES into an inactive form has been shown as carried out by caspase-3. At the gene level, PDE5 expression is regulated at two alternative promoters, PDE5A and PDE5A2, both of which are positively regulated by cyclic adenosine monophosphate and cGMP Downregulation of PDES has been observed in the penis of castrated animals; however, proof of androgen regulation of PDE5 gene requires examination of the smooth muscle content. Hyperoxia and hypoxia, respectively, regulate PDES expression positively and negatively. Hypoxic downregulation of PDE5 is a possible mechanism for the development of priapism. Conclusions. PDE5 can be regulated at protein and gene levels. In the penis, changes of PDE5 activity have been linked to its phosphorylation status, and downregulation of PDE5 expression has been associated with hypoxia. Lin CS. PDE5 regulation in the penile corpora nervosa. J Sex Med 2009;6(suppl 3):203-209.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 50 条
  • [31] The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation
    Jannini, Emmanuele A.
    McMahon, Chris
    Chen, Juza
    Aversa, Antonio
    Perelman, Michael
    [J]. JOURNAL OF SEXUAL MEDICINE, 2011, 8 (08) : 2135 - 2143
  • [32] TREATMENT OF PRIAPISM BY INJECTION OF ADRENALINE INTO THE CORPORA CAVERNOSA PENIS
    VANDRIEL, MF
    MOOIBROEK, JJ
    MENSINK, HJA
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1991, 25 (04): : 251 - 254
  • [33] Rupture of the corpora cavernosa. Report of 50 cases
    Benchekroun, A
    Lachkar, A
    Soumana, A
    Farih, MH
    Belahnech, Z
    Marzouk, M
    Faik, M
    [J]. ANNALES D UROLOGIE, 1998, 32 (05) : 315 - 319
  • [34] Phosphodiesterase type 5 inhibitors for erectile dysfunction
    Carson, CC
    Lue, TF
    [J]. BJU INTERNATIONAL, 2005, 96 (03) : 257 - 280
  • [35] Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate
    Zhang, Wenhao
    Zang, Ning
    Jiang, Yaoming
    Chen, Ping
    Wang, Xinghuan
    Zhang, Xinhua
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [36] Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors
    Vlachopoulos, Charalambos
    Ioakeimidis, Nikolaos
    Rokkas, Konstantinos
    Stefanadis, Christodoulos
    [J]. JOURNAL OF SEXUAL MEDICINE, 2009, 6 (03) : 658 - 674
  • [37] Corporoscopic excavation of the fibrosed corpora cavernosa for penile prosethesis implantation: Optical Corporotomy and Trans-Corporeal Resection, Shaeer's Technique
    Shaeer, Osama
    Shaeer, Ahmed
    [J]. JOURNAL OF SEXUAL MEDICINE, 2007, 4 (01) : 218 - 225
  • [38] Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5
    Sawant, Sanghapal D.
    Reddy, G. Lakshma
    Dar, Mohd Ishaq
    Srinivas, M.
    Gupta, Gourav
    Sahu, Promod Kumar
    Mahajan, Priya
    Nargotra, Amit
    Singh, Surjeet
    Sharma, Subhash C.
    Tikoo, Manoj
    Singh, Gurdarshan
    Vishwakarma, Ram A.
    Syed, Sajad Hussain
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) : 2121 - 2128
  • [39] Phosphodiesterase Type 5 Inhibitors as Adjunctive Therapy in the Management of Systolic Heart Failure
    Cvelich, Ramonna G.
    Roberts, Sarah C.
    Brown, Jamie N.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1551 - 1558
  • [40] Priming metabolism with the type 5 phosphodiesterase: the role of cGMP-hydrolyzing enzymes
    Campolo, Federica
    Pofi, Riccardo
    Venneri, Mary Anna
    Isidori, Andrea M.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2021, 60 : 298 - 305